These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 12563053)
41. Extent, reasons and consequences of off-labeled and unlicensed drug prescription in hospitalized children: a narrative review. Shuib W; Wu XY; Xiao F World J Pediatr; 2021 Aug; 17(4):341-354. PubMed ID: 34080130 [TBL] [Abstract][Full Text] [Related]
42. Unlicensed and off-label drug use in children: implications for safety. Choonara I Expert Opin Drug Saf; 2004 Mar; 3(2):81-3. PubMed ID: 15006712 [TBL] [Abstract][Full Text] [Related]
43. Drug utilization study in pediatric prescriptions of a university hospital in southern Brazil: off-label, unlicensed and high-alert medications. Dos Santos L; Heineck I Farm Hosp; 2012; 36(4):180-6. PubMed ID: 22030161 [TBL] [Abstract][Full Text] [Related]
44. [The incidence of prescriptions without marketing product license in a neonatal intensive care unit]. Avenel S; Bomkratz A; Dassieu G; Janaud JC; Danan C Arch Pediatr; 2000 Feb; 7(2):143-7. PubMed ID: 10701058 [TBL] [Abstract][Full Text] [Related]
45. Unlicensed and off-label prescription of drugs to children in primary health care: A systematic review. Andrade SRA; Santos PANM; Andrade PHS; da Silva WB J Evid Based Med; 2020 Nov; 13(4):292-300. PubMed ID: 33047516 [TBL] [Abstract][Full Text] [Related]
46. Off-label and unlicensed drug use in a pediatric intensive care unit of a tertiary care Spanish hospital. A descriptive study. Camacho Arroyo MT; Rivas Paterna AB; Meneses Monroy A; Cabrera García L; Blázquez González P; Mancebo Salas N; Rodríguez Leal L; Vargas Castrillón E Arch Argent Pediatr; 2023 Feb; 121(1):e202102550. PubMed ID: 36194689 [TBL] [Abstract][Full Text] [Related]
47. [Off-label and unlicensed drug use: Results from a pilot study in a pediatric intensive care unit]. García-López I; Fuentes-Ríos JE; Manrique-Rodríguez S; M Fernández-Llamazares C An Pediatr (Barc); 2017 Jan; 86(1):28-36. PubMed ID: 27151379 [TBL] [Abstract][Full Text] [Related]
48. Use of unlicensed and off-label medications in paediatric gastroenterology with a review of the commonly used formularies in the UK. Dick A; Keady S; Mohamed F; Brayley S; Thomson M; Lloyd BW; Heuschkel R; Afzal NA Aliment Pharmacol Ther; 2003 Feb; 17(4):571-5. PubMed ID: 12622766 [TBL] [Abstract][Full Text] [Related]
49. Unlicensed and off-label uses of medicines: definitions and clarification of terminology. Aronson JK; Ferner RE Br J Clin Pharmacol; 2017 Dec; 83(12):2615-2625. PubMed ID: 28779556 [TBL] [Abstract][Full Text] [Related]
50. A literature review on off-label drug use in children. Pandolfini C; Bonati M Eur J Pediatr; 2005 Sep; 164(9):552-8. PubMed ID: 15912383 [TBL] [Abstract][Full Text] [Related]
51. The awareness among paediatricians of off-label prescribing in children: a survey of Italian hospitals. Marchetti F; Bua J; Ventura A; Notarangelo LD; Di Maio S; Migliore G; Bonati M Eur J Clin Pharmacol; 2007 Jan; 63(1):81-5. PubMed ID: 17124577 [TBL] [Abstract][Full Text] [Related]
52. Prescribing for off-label use and unauthorized medicines in three paediatric wards in Finland, the status before and after the European Union Paediatric Regulation. Lindell-Osuagwu L; Hakkarainen M; Sepponen K; Vainio K; Naaranlahti T; Kokki H J Clin Pharm Ther; 2014 Apr; 39(2):144-53. PubMed ID: 24329556 [TBL] [Abstract][Full Text] [Related]
53. Outpatient antipsychotic drug use in children and adolescents in Germany between 2004 and 2011. Schröder C; Dörks M; Kollhorst B; Blenk T; Dittmann RW; Garbe E; Riedel O Eur Child Adolesc Psychiatry; 2017 Apr; 26(4):413-420. PubMed ID: 27623818 [TBL] [Abstract][Full Text] [Related]
54. Off-label and unlicensed drug use in hospitalized newborns in a Saudi tertiary care hospital: a cohort study. Mazhar F; Akram S; Haider N; Hadi MA; Sultana J Int J Clin Pharm; 2018 Jun; 40(3):700-703. PubMed ID: 29721741 [TBL] [Abstract][Full Text] [Related]
55. Unlicensed and off label drug use by children in the community: cross sectional study. Schirm E; Tobi H; de Jong-van den Berg LT BMJ; 2002 Jun; 324(7349):1312-3. PubMed ID: 12039826 [No Abstract] [Full Text] [Related]
56. [High prevalence of off-label and unlicensed drug prescribing in a Brazilian intensive care unit]. Ferreira Lde A; Ibiapina Cda C; Machado MG; Fagundes ED Rev Assoc Med Bras (1992); 2012; 58(1):82-7. PubMed ID: 22392321 [TBL] [Abstract][Full Text] [Related]
57. Off-label prescribing to children in the United States outpatient setting. Bazzano AT; Mangione-Smith R; Schonlau M; Suttorp MJ; Brook RH Acad Pediatr; 2009; 9(2):81-8. PubMed ID: 19329098 [TBL] [Abstract][Full Text] [Related]
58. Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. Conroy S; Choonara I; Impicciatore P; Mohn A; Arnell H; Rane A; Knoeppel C; Seyberth H; Pandolfini C; Raffaelli MP; Rocchi F; Bonati M; Jong G; de Hoog M; van den Anker J BMJ; 2000 Jan; 320(7227):79-82. PubMed ID: 10625257 [TBL] [Abstract][Full Text] [Related]
59. Off-label use of drugs in Italy: a prospective, observational and multicentre study. Pandolfini C; Impicciatore P; Provasi D; Rocchi F; Campi R; Bonati M; Acta Paediatr; 2002; 91(3):339-47. PubMed ID: 12022310 [TBL] [Abstract][Full Text] [Related]
60. Antibiotic usage, dosage and course length in children between 0 and 4 years. de Jong J; van den Berg PB; Visser ST; de Vries TW; de Jong-van den Berg LT Acta Paediatr; 2009 Jul; 98(7):1142-8. PubMed ID: 19397542 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]